Ownership history in ALGERT GLOBAL LLC · 14 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in BRIDGEBIO PHARMA INC (BBIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 341,048 | +226,185 | +196.9% | 0.41% | $26.1M | $76.49 |
| 2025 Q3 | ADDED | 114,863 | +50,110 | +77.4% | 0.10% | $6.0M | $51.94 |
| 2025 Q2 | ADDED | 64,753 | +41,153 | +174.4% | 0.06% | $2.8M | $43.18 |
| 2024 Q4 | REDUCED | 23,600 | -112,847 | -82.7% | 0.02% | $648K | $27.44 |
| 2024 Q3 | ADDED | 136,447 | +80,599 | +144.3% | 0.09% | $3.5M | $25.46 |
| 2024 Q2 | REDUCED | 55,848 | -33,558 | -37.5% | 0.05% | $1.4M | $25.33 |
| 2024 Q1 | ADDED | 89,406 | +1,830 | +2.1% | 0.11% | $2.8M | $30.92 |
| 2023 Q4 | ADDED | 87,576 | +22,012 | +33.6% | 0.14% | $3.5M | $40.37 |
| 2023 Q3 | ADDED | 65,564 | +25,680 | +64.4% | 0.08% | $1.7M | $26.37 |
| 2023 Q2 | REDUCED | 39,884 | -2,430 | -5.7% | 0.03% | $686K | $17.20 |
As of 2025 Q4 — sorted by position size